(Q31884618)

4 July 2017

1 reference

title

The potential place of chloroquine in the treatment of HIV-1-infected patients (English)

1 reference

4 July 2017

0 references

Boelaert JR

1

1 reference

4 July 2017

Piette J

series ordinal

2

1 reference

4 July 2017

Sperber K

series ordinal

3

1 reference

4 July 2017

publication date

1 February 2001

1 reference

Journal of Clinical Virology

4 July 2017

published in

1 reference

4 July 2017

volume

20

1 reference

4 July 2017

issue

3

1 reference

4 July 2017

page(s)

137-140

1 reference

Iron and oxidative stress as a mechanism for the enhanced production of human immunodeficiency virus by alveolar macrophages from otherwise healthy cigarette smokers

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900140-2

7 January 2021

Conference report: international conference on HIV and iron, Brugge 1997

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900140-2

7 January 2021

Antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900140-2

7 January 2021

Chloroquine exerts an additive in vitro anti-HIV type 1 effect when associated with didanosine and hydroxyurea

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900140-2

7 January 2021

Experimental results on chloroquine and AIDS-related opportunistic infections

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900140-2

7 January 2021

Antimalarial drugs inhibit phospholipase A2 activation and induction of interleukin 1beta and tumor necrosis factor alpha in macrophages: implications for their mode of action in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900140-2

7 January 2021

Neutrophils from patients with secondary haemosiderosis contain excessive amounts of autotoxic iron

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900140-2

7 January 2021

Inhibition of tubercle bacilli in cultured human macrophages by chloroquine used alone and in combination with streptomycin, isoniazid, pyrazinamide, and two metabolites of vitamin D3

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900140-2

7 January 2021

Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900140-2

7 January 2021

Inhibition of tumour necrosis factor (TNF) production by antimalarial drugs used in cerebral malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900140-2

7 January 2021

Effect of chronic chloroquine administration on iron loading in the liver and reticuloendothelial system and on oxidative responses by the alveolar macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900140-2

7 January 2021

Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900140-2

7 January 2021

Elevated tumor necrosis factor-alpha activation of human immunodeficiency virus type 1 subtype C in Southern Africa is associated with an NF-kappaB enhancer gain-of-function

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900140-2

7 January 2021

In vitro reactivation of human immunodeficiency virus 1 from latently infected, resting CD4+ T cells after bacterial stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900140-2

7 January 2021

Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900140-2

7 January 2021

The antiinflammatory and antiviral effects of hydroxychloroquine in two patients with acquired immunodeficiency syndrome and active inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900140-2

7 January 2021

Immune activation in HIV-infected African individuals. Italian-Ugandan AIDS cooperation program

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900140-2

7 January 2021

Iron chelation decreases NF-kappa B and HIV type 1 activation due to oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900140-2

7 January 2021

The anti-HIV-1 activity of chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900140-2

7 January 2021

Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900140-2

7 January 2021

Listeria monocytogenes meningitis and decreased phagocytosis associated with iron overload.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900140-2

7 January 2021

Linkage of cell-mediated immunity to iron metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900140-2

7 January 2021

Endemic Kaposi's sarcoma in Africa and local volcanic soils

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900140-2

7 January 2021

10.1016/S1386-6532(00)00140-2

Identifiers

DOI

1 reference

4 July 2017

1 reference